Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry
NonrulemakingOtherFDA-2025-D-1504-0002
Comments
36
Awaiting comments
Deadline
Closed on May 9, 2026
Closed May 9, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Mar 9, 2026
- Comment period
- Mar 9, 2026 – May 9, 2026
- Agency
- Food and Drug Administration (FDA)
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Analyzed 0 of 36 comments
0%· analysis in progress
Stance breakdown
—
Net support
Not yet analyzed36
Who commented
Breakdown by commenter type.
Not yet analyzed
36
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.